Rejuvenate Biomed is a science based healthy aging company developing prescription drugs in healthy aging by repositioning approved drugs.
Rejuvenate Biomed has raised $18.1M in total funding. The most recent round was Series B. The last funding was announced in October 2021.
Rejuvenate Biomed's investors include Vesalius Biocapital Partners, Centenara Labs, Agentschap Innoveren & Ondernemen.
Rejuvenate Biomed is headquartered in Heusden, Belgium.
Rejuvenate Biomed is a science based healthy aging company developing prescription drugs in healthy aging by repositioning approved drugs.
Rejuvenate Biomed is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rejuvenate Biomed — Funding & Investors." VCBacked, October 12, 2021, https://www.vcbacked.co/company/rejuvenate-biomed. Accessed September 15, 2026.
VCBacked. (2021). Rejuvenate Biomed — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/rejuvenate-biomed
{{cite web |title=Rejuvenate Biomed — Funding & Investors |url=https://www.vcbacked.co/company/rejuvenate-biomed |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated